THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
Executive compensation, broken down
Form 990 · Schedule J · 1 reported individual · Filing year 2024
- Base
- $231k
- Bonus
- —
- Other
- —
- Benefits
- —
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Institute Director key employee | $231k | — | — | — | $231k $240k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with Dallas-Fort Worth-Arlington, TX metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 5 unpaid individuals.
Down 4%
from 2023
From $241k in 2023 to $231k in 2024.
Estimated with Dallas-Fort Worth-Arlington, TX metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.